Correction: A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination
Oncogene
.
2021 Apr;40(14):2622-2623.
doi: 10.1038/s41388-021-01717-5.
Authors
Zeyuan Yu
#
1
,
Xiangyan Jiang
#
1
,
Long Qin
2
,
Haixiao Deng
1
,
Jianli Wang
2
,
Wen Ren
2
,
Hongbin Li
2
,
Lei Zhao
2
,
Huanxiang Liu
3
,
Hong Yan
4
,
Wengui Shi
2
,
Qi Wang
5
,
Changjiang Luo
1
,
Bo Long
1
,
Huinian Zhou
1
,
Hui Sun
6
,
Zuoyi Jiao
7
8
Affiliations
1
Department of General Surgery, Lanzhou University Second Hospital, 730000, Lanzhou, Gansu, China.
2
Cui-ying Experimental Center, Lanzhou University Second Hospital, 730000, Lanzhou, Gansu, China.
3
School of pharmacy, Lanzhou University, 730000, Lanzhou, Gansu, China.
4
Department of Pathology, Lanzhou University Second Hospital, 730000, Lanzhou, Gansu, China.
5
Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
6
Cui-ying Experimental Center, Lanzhou University Second Hospital, 730000, Lanzhou, Gansu, China. yaohy04@126.com.
7
Department of General Surgery, Lanzhou University Second Hospital, 730000, Lanzhou, Gansu, China. jiaozy@lzu.edu.cn.
8
Cui-ying Experimental Center, Lanzhou University Second Hospital, 730000, Lanzhou, Gansu, China. jiaozy@lzu.edu.cn.
#
Contributed equally.
PMID:
33707750
PMCID:
PMC8182770
DOI:
10.1038/s41388-021-01717-5
No abstract available
Publication types
Published Erratum